1795-04-6Relevant articles and documents
Synthesis and structure of novel disulfide(trisulfide)-containing thiophenes
Deng, Shi-Ren,Wu, Tao,Hu, Gao-Qiang,Li, Dan,Zhou, Yun-Hong,Li, Zao-Ying
, p. 71 - 78 (2007)
A novel trisulfide-containing thiophene, 1,5-dihydrothieno[3,4-e][1,2,3] trithiepine (5), and a disulfide analogue, 1,4-dihydrothieno[3,4-d][1,2]dithiine (4), were designed and synthesized. All the compounds were characterized by FT-IR, NMR, Raman, MS, an
Reaction of dimethyl disulfide with thiophene catalyzed by zeolite
Mashkina,Khairulina
, (2015)
Reaction of dimethyl disulfide with thiophene under the action of highly siliceous zeolite at 180-350°C and contact time 0.6-14 s resulted in formation of thioalkylation products, 2-(methylsulfanyl)- and 2,5-bis(methylsulfanyl)thiophenes and also alkylate
In vivo phenotypic drug discovery: Applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
Shao, Liming,Campbell, Una C.,Fang, Q. Kevin,Powell, Noel A.,Campbell, John E.,Jones, Philip G.,Hanania, Taleen,Alexandrov, Vadim,Morganstern, Irene,Sabath, Emily,Zhong, Hua M.,Large, Thomas H.,Spear, Kerry L.
supporting information, p. 1093 - 1101 (2016/07/06)
Phenotypic drug discovery (PDD) is increasingly being recognized as a viable compliment to target-based drug discovery (TDD). By measuring functional changes, typically at a systems level, PDD can facilitate the identification of compounds having a desirable pharmacology. This capability is particularly important when studying CNS diseases where drug efficacy may require modulation of multiple targets in order to overcome a robust, adaptive biological system. Here, we report the application of a mouse-based high-dimensional behavioral assay to the discovery and optimization of a structurally and mechanistically novel antipsychotic. Lead optimization focused on optimizing complex behavioral features and no explicit effort was made to identify the target (or targets) involved.